TREATMENT FOR DERMATOLOGICAL PATHOLOGIES

摘要

Skin inflammation in a human subject is reduced by administering to the subject a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1α.